Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof

Alkyl ether derivatives (I) are new. Alkyl ether derivatives of formula (I) and their salts are new. [Image] R 1, R 2 : H, halo, optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, alkylsulfonyl, arylsulfonyl, carbamoyl, heterocyclyl, NO 2, oxo or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IWAKAMI NOBORU, TAKAMATSU TAMOTSU, SAITOH AKIHITO
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IWAKAMI NOBORU
TAKAMATSU TAMOTSU
SAITOH AKIHITO
description Alkyl ether derivatives (I) are new. Alkyl ether derivatives of formula (I) and their salts are new. [Image] R 1, R 2 : H, halo, optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, alkylsulfonyl, arylsulfonyl, carbamoyl, heterocyclyl, NO 2, oxo or optionally protected hydroxy, amino or carboxyl; R 3 : optionally substituted alkylamino or optionally protected amino or hydroxy; A : 5 or 6 membered heteroaryl or benzene; m, n : 1-6; and p : 1-3. ACTIVITY : Calcium-Antagonist. MECHANISM OF ACTION : Neuroprotective; CNS-Gen. In nerve regeneration models in SD rats 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol (Ia) hydrochloric acid salt administered at 1 mg/kg/day orally for 13 days increased regeneration by 186% compared to a control.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL217872BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL217872BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL217872BB13</originalsourceid><addsrcrecordid>eNqNjLEKwjAUALs4iPoPb1TwDWmRulpRHBwc3ERKbF9JMCQhCdVUHPxzK7i5ON1wxw2T10pdowIKghzU5GTLg2wJjAMOnqsAH0OmmcNNyEqA9L1g-MjwlOKU4YV0Z4KQxgrSuMCoZv3M3OMZrDM2qidmyDsKsY7aqN_xOBk0XHmafDlKYLs5rndI1pTkLa9IUygP-5TlyzwtCpb9kbwBlYtHOA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof</title><source>esp@cenet</source><creator>IWAKAMI NOBORU ; TAKAMATSU TAMOTSU ; SAITOH AKIHITO</creator><creatorcontrib>IWAKAMI NOBORU ; TAKAMATSU TAMOTSU ; SAITOH AKIHITO</creatorcontrib><description>Alkyl ether derivatives (I) are new. Alkyl ether derivatives of formula (I) and their salts are new. [Image] R 1, R 2 : H, halo, optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, alkylsulfonyl, arylsulfonyl, carbamoyl, heterocyclyl, NO 2, oxo or optionally protected hydroxy, amino or carboxyl; R 3 : optionally substituted alkylamino or optionally protected amino or hydroxy; A : 5 or 6 membered heteroaryl or benzene; m, n : 1-6; and p : 1-3. ACTIVITY : Calcium-Antagonist. MECHANISM OF ACTION : Neuroprotective; CNS-Gen. In nerve regeneration models in SD rats 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol (Ia) hydrochloric acid salt administered at 1 mg/kg/day orally for 13 days increased regeneration by 186% compared to a control.</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140829&amp;DB=EPODOC&amp;CC=PL&amp;NR=217872B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140829&amp;DB=EPODOC&amp;CC=PL&amp;NR=217872B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IWAKAMI NOBORU</creatorcontrib><creatorcontrib>TAKAMATSU TAMOTSU</creatorcontrib><creatorcontrib>SAITOH AKIHITO</creatorcontrib><title>Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof</title><description>Alkyl ether derivatives (I) are new. Alkyl ether derivatives of formula (I) and their salts are new. [Image] R 1, R 2 : H, halo, optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, alkylsulfonyl, arylsulfonyl, carbamoyl, heterocyclyl, NO 2, oxo or optionally protected hydroxy, amino or carboxyl; R 3 : optionally substituted alkylamino or optionally protected amino or hydroxy; A : 5 or 6 membered heteroaryl or benzene; m, n : 1-6; and p : 1-3. ACTIVITY : Calcium-Antagonist. MECHANISM OF ACTION : Neuroprotective; CNS-Gen. In nerve regeneration models in SD rats 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol (Ia) hydrochloric acid salt administered at 1 mg/kg/day orally for 13 days increased regeneration by 186% compared to a control.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAUALs4iPoPb1TwDWmRulpRHBwc3ERKbF9JMCQhCdVUHPxzK7i5ON1wxw2T10pdowIKghzU5GTLg2wJjAMOnqsAH0OmmcNNyEqA9L1g-MjwlOKU4YV0Z4KQxgrSuMCoZv3M3OMZrDM2qidmyDsKsY7aqN_xOBk0XHmafDlKYLs5rndI1pTkLa9IUygP-5TlyzwtCpb9kbwBlYtHOA</recordid><startdate>20140829</startdate><enddate>20140829</enddate><creator>IWAKAMI NOBORU</creator><creator>TAKAMATSU TAMOTSU</creator><creator>SAITOH AKIHITO</creator><scope>EVB</scope></search><sort><creationdate>20140829</creationdate><title>Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof</title><author>IWAKAMI NOBORU ; TAKAMATSU TAMOTSU ; SAITOH AKIHITO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL217872BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IWAKAMI NOBORU</creatorcontrib><creatorcontrib>TAKAMATSU TAMOTSU</creatorcontrib><creatorcontrib>SAITOH AKIHITO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IWAKAMI NOBORU</au><au>TAKAMATSU TAMOTSU</au><au>SAITOH AKIHITO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof</title><date>2014-08-29</date><risdate>2014</risdate><abstract>Alkyl ether derivatives (I) are new. Alkyl ether derivatives of formula (I) and their salts are new. [Image] R 1, R 2 : H, halo, optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, alkylsulfonyl, arylsulfonyl, carbamoyl, heterocyclyl, NO 2, oxo or optionally protected hydroxy, amino or carboxyl; R 3 : optionally substituted alkylamino or optionally protected amino or hydroxy; A : 5 or 6 membered heteroaryl or benzene; m, n : 1-6; and p : 1-3. ACTIVITY : Calcium-Antagonist. MECHANISM OF ACTION : Neuroprotective; CNS-Gen. In nerve regeneration models in SD rats 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol (Ia) hydrochloric acid salt administered at 1 mg/kg/day orally for 13 days increased regeneration by 186% compared to a control.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL217872BB1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Alkyl ether derivative or a salt thereof, which is a 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetydynol or a salt thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A21%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IWAKAMI%20NOBORU&rft.date=2014-08-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL217872BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true